Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Feb 20, 2024
Wensheng Fan, CEO and Co-Founder of Spectral AI, understands that the ability to accurately determine whether a wound will heal is currently lacking in wound care. The Spectral AI predictive imaging technology uses multispectral imaging and AI to assess the viability of injured tissue and predict wound healing outcomes. The DeepView device is portable and easy to use, providing fast analysis and saving time in determining the appropriate next steps to treat acute and chronic wounds.
Wensheng explains, "Ten years ago when we were founded, we were doing bed sore early detections. Then we transitioned into burn wounds, and the latest adventure is for the diabetic foot ulcer. We see all these acute and chronic wounds, and they all need a common thing to let physicians, clinicians, and patients know whether these wounds will heal or not. That's a simple question, but so far, we don't have a good answer to it with the technology on the market."
"For example, let's use acute burn wounds. The current standard of care, per se, is actually the physicians have to wait and see, sometimes up to 21 days, to determine if a burn will heal or not. Why are they so careful? Because visually the wound changes and if it's a non-healing burn, what they need to do is clinically debride that area to take out the dead tissue so that they can put the skin substitute and other products on it to help the overall healing."
"We look at the wound from near UV lights across the visible band seen in the human eye and into the near IR lights. We capture the injured tissue's spectral signature, like a fingerprint for those non-healing tissues. We found it and then realized ten years ago that the human brain is not good enough to process that information. We introduced AI, machine learning, deep learning, and all those advanced technologies in identifying non-healing burn tissue since 2014. So far, we have achieved 92% accuracy on day one of looking at a burn wound to decide where that burn wound will never heal or if there are healing tissues that you don't need to take into surgical consideration. So, this technology will become an assistant to burn professionals and ER doctors in deciding how to process the patients during that first encounter."
#SpectralAI #AI #ArtificialIntelligence #WoundHealing #DiabeticFootUlcers #BurnInjuries
